Prevention of late deaths in X-irradiated mice by injected hematopoietic cells from homologous newborn donors
- 31 January 1959
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Legacy Content
- Vol. 196 (2), 441-444
- https://doi.org/10.1152/ajplegacy.1959.196.2.441
Abstract
Previous studies have shown that the injection of spleen cells from normal adult parental strain (A-strain) mice into sublethally x-irradiated (500 r) F1 hybrid mice ((LxA)F1), elicits delayed deaths in 100% of the animals. This lethal effect is elicited, as shown here, also by spleen cells from adult L-strain mice, but not by spleen cells derived from newborn (1–2-day-old) parental strain mice. Following supralethal whole-body x-irradiation (870 r) of LAF mice, the injection of cells from spleen or liver of newborn A-strain mice afforded up to 100% protection against death by 30 days postirradiation; no late ‘homologous deaths’ were seen in the mice which received spleen cells from the newborn A-mice, in contrast with that observed when hematopoietic cells from adult A-mice are injected. The data imply that spleen cells from newborn mice are immunologically nonreactive, and lend further support to the hypothesis that late homologous deaths (in the context employed here) results primarily from an immunological reaction of the injected cells against the host.Keywords
This publication has 4 references indexed in Scilit:
- Preclusion of Secondary Phase of Irradiation Syndrome by Inoculation of Fetal Hematopoietic Tissue Following Lethal Total-Body X IrradiationJNCI Journal of the National Cancer Institute, 1958
- Tissue transplantation in the radiation chimeraJournal of Cellular and Comparative Physiology, 1957
- HOMOLOGOUS BONE MARROW IN THE TREATMENT OF RADIATION INJURY IN MICE1957
- Mortality and Skin Transplantability in X-Irradiated Mice Receiving Isologous, Homologous or Heterologous Bone Marrow.Experimental Biology and Medicine, 1956